United Therapeutics Corporation (UTHR) ownership: Avoro Capital Advisors LLC 16% · institutions 100% (13F 2026-03-31). Insider activity, 90 days: Routine (843 sales, 0 open-market buys). 3 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 5399649.00 | $3.20B | 12.7% | 2026-03-31 |
| Vanguard | 4297115.00 | $2.55B | 10.1% | 2026-03-31 |
| Avoro Capital Advisors LLC | 2630000.00 | $1.56B | 6.2% | 2026-03-31 |
| Wellington Management | 2264247.00 | $1.34B | 5.3% | 2026-03-31 |
| State Street | 1843963.00 | $1.09B | 4.3% | 2026-03-31 |
| Renaissance Technologies | 1787019.00 | $1.06B | 4.2% | 2026-03-31 |
| Geode Capital Management | 1233029.00 | $729.92M | 2.9% | 2026-03-31 |
| Janus Henderson | 866930.00 | $514.02M | 2.0% | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 | |
| Sell | null | 2026-08-21 |
Back to UTHR overview · UTHR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.